{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:44:44Z","timestamp":1789145084286,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2011-0030001"],"award-info":[{"award-number":["2011-0030001"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2014R1A5A20009936"],"award-info":[{"award-number":["2014R1A5A20009936"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1A6A3A11032239"],"award-info":[{"award-number":["NRF-2017R1A6A3A11032239"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Osteoclasts (OCs) are bone-resorbing cells that originate from hematopoietic stem cells and develop through the fusion of mononuclear myeloid precursors. Dysregulation of OC development causes bone disorders such as osteopetrosis, osteoporosis, and rheumatoid arthritis. Although the molecular mechanisms underlying osteoclastogenesis have been well established, the means by which OCs maintain their survival during OC development remain unknown. We found that Ninjurin1 (Ninj1) expression is dynamically regulated during osteoclastogenesis and that <jats:italic>Ninj1<\/jats:italic>\n            <jats:sup>\u2212\/\u2212<\/jats:sup> mice exhibit increased trabecular bone volume owing to impaired OC development. Ninj1 deficiency did not alter OC differentiation, transmigration, fusion, or actin ring formation but increased Caspase-9-dependent intrinsic apoptosis in prefusion OCs (preOCs). Overexpression of Ninj1 enhanced the survival of mouse macrophage\/preOC RAW264.7 cells in osteoclastogenic culture, suggesting that Ninj1 is important for the survival of preOCs. Finally, analysis of publicly available microarray data sets revealed a potent correlation between high <jats:italic>NINJ1<\/jats:italic> expression and destructive bone disorders in humans. Our data indicate that Ninj1 plays an important role in bone homeostasis by enhancing the survival of preOCs.<\/jats:p>","DOI":"10.1038\/s12276-018-0201-3","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T09:05:23Z","timestamp":1548839123000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts"],"prefix":"10.1038","volume":"51","author":[{"given":"Sung-Jin","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-2231","authenticated-orcid":false,"given":"Taekwon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo Taeg","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrm3254","volume":"13","author":"F Long","year":"2012","unstructured":"Long, F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 13, 27\u201338 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"201_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"201_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2011.23","volume":"7","author":"JR Edwards","year":"2011","unstructured":"Edwards, J. R. & Mundy, G. R. Advances in osteoclast biology: old findings and new insights from mouse models. Nat. Rev. Rheumatol. 7, 235\u2013243 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"201_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1196\/annals.1402.071","volume":"1116","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. The role of NFAT in osteoclast formation. Ann. N. Y Acad. Sci. 1116, 227\u2013237 (2007).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"201_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","volume":"42","author":"Q Zhao","year":"2010","unstructured":"Zhao, Q., Wang, X., Liu, Y., He, A. & Jia, R. NFATc1: functions in osteoclasts. Int J. Biochem Cell Biol. 42, 576\u2013579 (2010).","journal-title":"Int J. Biochem Cell Biol."},{"key":"201_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20051123","volume":"202","author":"A Vignery","year":"2005","unstructured":"Vignery, A. Macrophage fusion: the making of osteoclasts and giant cells. J. Exp. Med 202, 337\u2013340 (2005).","journal-title":"J. Exp. Med"},{"key":"201_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ejcb.2008.01.001","volume":"87","author":"F Saltel","year":"2008","unstructured":"Saltel, F., Chabadel, A., Bonnelye, E. & Jurdic, P. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur. J. Cell Biol. 87, 459\u2013468 (2008).","journal-title":"Eur. J. Cell Biol."},{"key":"201_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A. & Helfrich, M. H. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat. Rev. Endocrinol. 9, 522\u2013536 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"201_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000464","volume":"9","author":"R Layfield","year":"2007","unstructured":"Layfield, R. The molecular pathogenesis of Paget disease of bone. Expert Rev. Mol. Med 9, 1\u201313 (2007).","journal-title":"Expert Rev. Mol. Med"},{"key":"201_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.bor.0000231912.24740.a5","volume":"18","author":"K Sato","year":"2006","unstructured":"Sato, K. & Takayanagi, H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr. Opin. Rheumatol. 18, 419\u2013426 (2006).","journal-title":"Curr. Opin. Rheumatol."},{"key":"201_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.metabol.2015.07.011","volume":"64","author":"P Makras","year":"2015","unstructured":"Makras, P., Delaroudis, S. & Anastasilakis, A. D. Novel therapies for osteoporosis. Metabolism 64, 1199\u20131214 (2015).","journal-title":"Metabolism"},{"key":"201_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0896-6273(00)80166-X","volume":"17","author":"T Araki","year":"1996","unstructured":"Araki, T. & Milbrandt, J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 17, 353\u2013361 (1996).","journal-title":"Neuron"},{"key":"201_CR13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/cdd.2009.78","volume":"16","author":"HJ Lee","year":"2009","unstructured":"Lee, H. J. et al. Ninjurin1 mediates macrophage-induced programmed cell death during early ocular development. Cell Death Differ. 16, 1395\u20131407 (2009).","journal-title":"Cell Death Differ."},{"key":"201_CR14","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1074\/jbc.M113.498212","volume":"289","author":"BJ Ahn","year":"2014","unstructured":"Ahn, B. J. et al. Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice. J. Biol. Chem. 289, 3328\u20133338 (2014).","journal-title":"J. Biol. Chem."},{"key":"201_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ana.22519","volume":"70","author":"I Ifergan","year":"2011","unstructured":"Ifergan, I. et al. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Ann. Neurol. 70, 751\u2013763 (2011).","journal-title":"Ann. Neurol."},{"key":"201_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3892\/ijo.2015.3296","volume":"48","author":"MW Shin","year":"2016","unstructured":"Shin, M. W. et al. Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding. Int J. Oncol. 48, 821\u2013828 (2016).","journal-title":"Int J. Oncol."},{"key":"201_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1165\/rcmb.2014-0354OC","volume":"53","author":"C Jennewein","year":"2015","unstructured":"Jennewein, C. et al. Contribution of Ninjurin1 to Toll-like receptor 4 signaling and systemic inflammation. Am. J. Respir. Cell Mol. Biol. 53, 656\u2013663 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"201_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/jcb.25872","volume":"118","author":"SJ Bae","year":"2017","unstructured":"Bae, S. J. et al. Ninjurin1 assembles into a homomeric protein complex maintained by N-linked glycosylation. J. Cell Biochem 118, 2219\u20132230 (2017).","journal-title":"J. Cell Biochem"},{"key":"201_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","volume":"190","author":"F Arai","year":"1999","unstructured":"Arai, F. et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor \u03baB (RANK) receptors. J. Exp. Med 190, 1741\u20131754 (1999).","journal-title":"J. Exp. Med"},{"key":"201_CR20","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.4049\/jimmunol.177.7.4360","volume":"177","author":"A Mochizuki","year":"2006","unstructured":"Mochizuki, A. et al. Identification and characterization of the precursors committed to osteoclasts induced by tnf-related activation-induced cytokine\/receptor activator of NF- B ligand. J. Immunol. 177, 4360\u20134368 (2006).","journal-title":"J. Immunol."},{"key":"201_CR21","doi-asserted-by":"publisher","first-page":"21926","DOI":"10.1074\/jbc.M113.532358","volume":"289","author":"BJ Ahn","year":"2014","unstructured":"Ahn, B. J. et al. Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics. J. Biol. Chem. 289, 21926\u201321936 (2014).","journal-title":"J. Biol. Chem."},{"key":"201_CR22","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1242\/jcs.069872","volume":"123","author":"W Zou","year":"2010","unstructured":"Zou, W. et al. Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts. J. Cell Sci. 123, 2955\u20132963 (2010).","journal-title":"J. Cell Sci."},{"key":"201_CR23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1359\/jbmr.060821","volume":"21","author":"F Saltel","year":"2006","unstructured":"Saltel, F. et al. Transmigration: a new property of mature multinucleated osteoclasts. J. Bone Miner. Res 21, 1913\u20131923 (2006).","journal-title":"J. Bone Miner. Res"},{"key":"201_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5312\/wjo.v3.i12.212","volume":"3","author":"L Xing","year":"2012","unstructured":"Xing, L., Xiu, Y. & Boyce, B. F. Osteoclast fusion and regulation by RANKL-dependent and independent factors. World J. Orthop. 3, 212\u2013222 (2012).","journal-title":"World J. Orthop."},{"key":"201_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1359\/jbmr.070401","volume":"22","author":"M Yagi","year":"2007","unstructured":"Yagi, M. et al. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J. Bone Miner. Res 22, 992\u20131001 (2007).","journal-title":"J. Bone Miner. Res"},{"key":"201_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2659","volume":"18","author":"K Fujita","year":"2012","unstructured":"Fujita, K. et al. Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat. Med 18, 589\u2013594 (2012).","journal-title":"Nat. Med"},{"key":"201_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.bbrc.2008.10.076","volume":"377","author":"R Iwasaki","year":"2008","unstructured":"Iwasaki, R. et al. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys. Res Commun. 377, 899\u2013904 (2008).","journal-title":"Biochem Biophys. Res Commun."},{"key":"201_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","volume":"1240","author":"SL Teitelbaum","year":"2011","unstructured":"Teitelbaum, S. L. The osteoclast and its unique cytoskeleton. Ann. N. Y Acad. Sci. 1240, 14\u201317 (2011).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"201_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum, S. L. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170, 427\u2013435 (2007).","journal-title":"Am. J. Pathol."},{"key":"201_CR30","doi-asserted-by":"publisher","first-page":"32968","DOI":"10.1074\/jbc.M109.001016","volume":"284","author":"M Yu","year":"2009","unstructured":"Yu, M., Moreno, J. L., Stains, J. P. & Keegan, A. D. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. J. Biol. Chem. 284, 32968\u201332979 (2009).","journal-title":"J. Biol. Chem."},{"key":"201_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-74","volume":"11","author":"KH Park","year":"2013","unstructured":"Park, K. H. et al. Zinc inhibits osteoclast differentiation by suppression of Ca 2+-Calcineurin-NFATc1 signaling pathway. Cell Commun. Signal 11, 74 (2013).","journal-title":"Cell Commun. Signal"},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1073\/pnas.1316932111","volume":"111","author":"C Watanabe","year":"2014","unstructured":"Watanabe, C. et al. Stability of mRNA influences osteoporotic bone mass via CNOT3. Proc. Natl Acad. Sci. USA 111, 2692\u20132697 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ceb.2004.09.008","volume":"16","author":"C Garrido","year":"2004","unstructured":"Garrido, C. & Kroemer, G. Life\u2019s smile, death\u2019s grin: vital functions of apoptosis-executing proteins. Curr. Opin. Cell Biol. 16, 639\u2013646 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"201_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"G Kroemer","year":"2009","unstructured":"Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3\u201311 (2009).","journal-title":"Cell Death Differ."},{"key":"201_CR35","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1359\/jbmr.080511","volume":"23","author":"MP Whyte","year":"2008","unstructured":"Whyte, M. P. et al. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J. Bone Miner. Res 23, 1698\u20131707 (2008).","journal-title":"J. Bone Miner. Res"},{"key":"201_CR36","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1073\/pnas.1221242110","volume":"110","author":"SJ Cho","year":"2013","unstructured":"Cho, S. J. et al. Ninjurin1, a target ofp53, regulates p53 expression and p53-dependent cell survival, senescence, and radiation-induced mortality. Proc. Natl Acad. Sci. USA 110, 9362\u20139367 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","volume":"42","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore, A., Cappariello, A. & Teti, A. Genetics, pathogenesis and complications of osteopetrosis. Bone 42, 19\u201329 (2008).","journal-title":"Bone"},{"key":"201_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/s10165-011-0530-8","volume":"22","author":"I Nakamura","year":"2012","unstructured":"Nakamura, I., Takahashi, N., Jimi, E., Udagawa, N. & Suda, T. Regulation of osteoclast function. Mod. Rheumatol. 22, 167\u2013177 (2012).","journal-title":"Mod. Rheumatol."},{"key":"201_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","volume":"305","author":"ZH Lee","year":"2003","unstructured":"Lee, Z. H. & Kim, H.-H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys. Res Commun. 305, 211\u2013214 (2003).","journal-title":"Biochem Biophys. Res Commun."},{"key":"201_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/35004599","volume":"404","author":"K Akashi","year":"2000","unstructured":"Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193\u2013197 (2000).","journal-title":"Nature"},{"key":"201_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri, M. & Takayanagi, H. The molecular understanding of osteoclast differentiation. Bone 40, 251\u2013264 (2007).","journal-title":"Bone"},{"key":"201_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/blood.V99.1.111","volume":"99","author":"XM Dai","year":"2002","unstructured":"Dai, X.-M. et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111\u2013120 (2002).","journal-title":"Blood"},{"key":"201_CR43","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall, W. C. et al. RANK is essential for osteoclast and lymph node development. Gene Dev. 13, 2412\u20132424 (1999).","journal-title":"Gene Dev."},{"key":"201_CR44","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl Acad. Sci. USA 97, 1566\u20131571 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR45","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/nm1514","volume":"12","author":"SH Lee","year":"2006","unstructured":"Lee S. H. et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med 12, 1403\u20131409 (2006).","journal-title":"Nat. Med"},{"key":"201_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20050645","volume":"202","author":"M Yagi","year":"2005","unstructured":"Yagi, M. et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med 202, 345\u2013351 (2005).","journal-title":"J. Exp. Med"},{"key":"201_CR47","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/jcb.22640","volume":"110","author":"MJ Oursler","year":"2010","unstructured":"Oursler, M. J. Recent advances in understanding the mechanisms of osteoclast precursor fusion. J. Cell Biochem 110, 1058\u20131062 (2010).","journal-title":"J. Cell Biochem"},{"key":"201_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13018-015-0152-5","volume":"10","author":"S Mollazadeh","year":"2015","unstructured":"Mollazadeh, S., Fazly Bazzaz, B. S. & Kerachian, M. A. Role of apoptosis in pathogenesis and treatment of bone-related diseases. J. Orthop. Surg. Res 10, 15 (2015).","journal-title":"J. Orthop. Surg. Res"},{"key":"201_CR49","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1073\/pnas.1711814114","volume":"114","author":"HJ Yang","year":"2017","unstructured":"Yang, H. J. et al. Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner. Proc. Natl Acad. Sci. USA 114, 11500\u201311505 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR50","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","volume":"10","author":"H Glantschnig","year":"2003","unstructured":"Glantschnig, H., Fisher, J., Wesolowski, G., Rodan, G. & Reszka, A. M.-C. S. F. TNF\u03b1 and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase. Cell Death Differ. 10, 1165\u20131177 (2003).","journal-title":"Cell Death Differ."},{"key":"201_CR51","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1074\/jbc.M410480200","volume":"280","author":"T Sugatani","year":"2005","unstructured":"Sugatani, T. & Hruska, K. A. Akt1\/Akt2 and mammalian target of rapamycin\/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J. Biol. Chem. 280, 3583\u20133589 (2005).","journal-title":"J. Biol. Chem."},{"key":"201_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r32","volume":"14","author":"F Loayza-Puch","year":"2013","unstructured":"Loayza-Puch, F. et al. p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome Biol. 14, R32 (2013).","journal-title":"Genome Biol."},{"key":"201_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijsu.2015.04.050","volume":"20","author":"R Song","year":"2015","unstructured":"Song, R., Tian, K., Wang, W. & Wang, L. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K\/AKT\/mTOR pathway. Int J. Surg. 20, 80\u201387 (2015).","journal-title":"Int J. Surg."},{"key":"201_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.200507106","volume":"172","author":"X Wang","year":"2006","unstructured":"Wang, X. et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115\u2013125 (2006).","journal-title":"J. Cell Biol."},{"key":"201_CR55","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1074\/jbc.M115.702571","volume":"291","author":"Y Qiao","year":"2016","unstructured":"Qiao, Y. et al. AP-1 Is a key regulator of proinflammatory cytokine tnfalpha-mediated triple-negative breast cancer progression. J. Biol. Chem. 291, 5068\u20135079 (2016).","journal-title":"J. Biol. Chem."},{"key":"201_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/157339709788298428","volume":"5","author":"S Roux","year":"2009","unstructured":"Roux, S. & Brown, J. P. Osteoclast apoptosis in rheumatic diseases characterized by a high level of bone resorption (osteoporosis, rheumatoid arthritis, myeloma and Paget\u2019s disease of bone). Curr. Rheumatol. Rev. 5, 98\u2013110 (2009).","journal-title":"Curr. Rheumatol. Rev."},{"key":"201_CR57","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","volume":"11","author":"R Pacifici","year":"1996","unstructured":"Pacifici, R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res 11, 1043\u20131051 (1996).","journal-title":"J. Bone Miner. Res"},{"key":"201_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/ar3380","volume":"13","author":"T Braun","year":"2011","unstructured":"Braun, T. & Zwerina, J. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther. 13, 235 (2011).","journal-title":"Arthritis Res Ther."},{"key":"201_CR59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1359\/jbmr.070207","volume":"22","author":"N Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya, N., Khosla, S., Atkinson, E. J., McCready, L. K. & Riggs, B. L. Effect of blockade of TNF-\u03b1 and interleukin-1 action on bone resorption in early postmenopausal women. J. Bone Miner. Res 22, 724\u2013729 (2007).","journal-title":"J. Bone Miner. Res"},{"key":"201_CR60","doi-asserted-by":"publisher","first-page":"E2731","DOI":"10.1073\/pnas.1403471111","volume":"111","author":"GN Yin","year":"2014","unstructured":"Yin, G. N. et al. Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse. Proc. Natl Acad. Sci. USA 111, E2731\u2013E2740 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR61","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1210\/jc.2015-3336","volume":"101","author":"NK Sharma","year":"2016","unstructured":"Sharma, N. K. et al. Tissue-specific and genetic regulation of insulin sensitivity-associated transcripts in African Americans. J. Clin. Endocrinol. Metab. 101, 1455\u20131468 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"201_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard, P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis. Osteoporos. Int 18, 427\u2013444 (2007).","journal-title":"Osteoporos. Int"},{"key":"201_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/03008207.2016.1171858","volume":"57","author":"J Peng","year":"2016","unstructured":"Peng, J. et al. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice. Connect Tissue Res 57, 277\u2013289 (2016).","journal-title":"Connect Tissue Res"}],"updated-by":[{"DOI":"10.1038\/s12276-025-01475-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000}}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0201-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:05:43Z","timestamp":1749002743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1038\/s12276-018-0201-3","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"19 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After online publication of this article, the authors noticed an error in the Fig. 3d section. In Fig. 3d, the authors identified that the WT result (12 hr, lower left) was unintentionally duplicated with the <i>Ninj1<\/i><sup>\u2212\/\u2212<\/sup> result (12 hr, upper right) during the data organization process. To rectify this duplication, we prepared the correct version of this figure with the proper <i>Ninj1<\/i><sup>\u2212\/\u2212<\/sup> result (12 hr, upper right). Fig. 3d reveals that transmigration of RANKL-stimulated preosteoclast (red) through the osteoblast monolayer (green) is similar between WT and Ninj1 KO. Thus, our conclusion of a crucial role of Ninj1 in preosteoclast survival is not influenced by the correction.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s12276-025-01475-4","URL":"https:\/\/doi.org\/10.1038\/s12276-025-01475-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}